HA-REACT Joint Action WP4 Testing and Linkage to care Methods:

Slides:



Advertisements
Similar presentations
MDM Harm Reduction (needle exchange) program in Kabul-Afghanistan.
Advertisements

HIV and Hepatitis C in non- MSM Rural Communities: Issues and Interventions Shari Wells-Weiss, CASAC Director of Prevention Services Southern Tier AIDS.
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Edo Agustian Indonesian Drug Users Network Experiencing HCV Infection – the treatment, the reality and the possibilities for Cure.
Improving health and protecting human rights Improving health and protecting human rights for individuals, communities, and society Harm reduction and.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
Social Work Framework for Outreach Work Presentation 7.
HIV/AIDS Workplace Programme +27 (0) Focus of Services The City of Cape Town has identified HIV/AIDS/TB as one of it’s four strategic priorities.
HIV and drug prevention in Estonia Harm reduction services
Kazakhstan Gulnara Darbekova (1), Nadezhda Kozachenko (1), Irina Mingazova (1), Alexander Solodov (1), Natalia Kartashova (1), Zita Lazzarini (2,3), Patricia.
HEINEKEN International Making HIV programmes work The Heineken HIV programme- First ten years.
Violation of Rights of People Living with HIV/AIDS in Health Care Setting in Odessa, Ukraine Odessa, Ukraine August 2008 Kostiantyn Zverkov, Director of.
Law enforcement and Harm Reduction in practice: experiences from Kyrgyzstan Aleksandr Zelichenko, Director of Public Fund Central-Asian Center on Drug.
Application of Patients’ Rights in Cross-Border Health Care Regional meeting and workshop February 2009 Budapest ŠKUC – Magnus, SLOVENIA Miran Šolinc.
Results from the Spanish experience: A comprehensive approach to HIV and HCV in prisons MERCEDES GALLIZO LLAMAS Secretary-General of Spanish Prison Administration.
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
Annual report 2010: the state of the drugs problem in Europe.
The policy development for introducing of the oral fluid based rapid HIV test kit in Thailand Writers in the 2009 Write Workshop (WHO Bulletin)
Essential package of targeted interventions for MARA Romania Experience.
Lydia H. Guterman Consultant, Open Society Institute September 25, 2008 Sofia, Bulgaria Many thanks to the Harm Reduction Coalition for partial content.
Olivia Chang, MPH Research and Program Manager Pangaea Global AIDS
Harm Reduction International
Substance Abuse Treatment and HIV in Iran
Global Fund in Estonia Kaja Põlluste, MD, MPH Department of Public Health & Department of Internal Diseases University of Tartu Estonia.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
AIDS 2014 Workshop on increasing access to TB services as part of integrated care for people who inject drugs Integrating TB services.
HIV in India David S. Hausner American Embassy School 8 th Grade Population Project 24 February 2012.
From evidence to commitment to action: implementing HIV prevention measures in prisons in Ukraine XVI International AIDS Conference Toronto, 15 August.
High HIV, HBV and HCV Prevalence among People Who Inject Drugs: Results from the First Integrated Bio-behavioral Survey of PWID in Mozambique Authors:
Our Mission Based on the humanistic ideas to enhance the quality of life of the people living with HIV/AIDS by means of joint efforts of all who is concerned,
Enabling Policy Environments for more Effective HIV Responses among Gay and Bisexual and other Men who have Sex with Men Vitaliy Karanda, Program Support.
Edo Agustian Indonesian Drug Users Network Meaningful Involvement of PWID in Hep C advocacy in Indonesia.
HIV testing guidance: know, treat, prevent Spotlight: HIV/AIDS European Centre for Disease Prevention and Control Stockholm, 1 December 2010.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
An Age of hope: a National Effort for Corrections, Rehabilitation and Social Re-integration of Offenders PRESENTATION ON CURRENT HIV AND AIDS PROJECTS.
Thematic Priorities for ATF Applications Presentation by Secretariat of Council for the AIDS Trust Fund in Briefing Session on 27 July
Integrated services for people who use drugs in vertical health care systems: challenges and solutions Kostyantyn Dumchev, MD, MPH July 19, st.
Conflict of Interest “No conflicts of interest to declare”.
IAS Satellite Session 25th July 2017 Daniel Were, PhD
SUPPORT AND RESOURCES CENTRE FOR THOSE AFFECTED BY HIV/AIDS
Cascade of care for people who use drugs - opportunities for integration and scale up of harm reduction services and other evidence based interventions.
SITUATION WITH TUBERCULOSIS AND OTHER INFECTIOUS DISEASES IN LATVIAN PRISONS PROGNOSIS AND CHALLENGES Riga, 29 – 30 May 2008.
Riga city Council Welfare department HIV prevention
Northern Dimension HIV/AIDS Group meeting Tallin, April 2008
Fabienne Hariga Senior Adviser, HIV/AIDS Section
Effective HIV & SRH Responses Among Sex Workers and other Key Populations Module 1: National Data.
BIRUTE SEMENAITE, MEDICAL DIVISION OF THE PRISON DEPARTMENT
Eurasian Harm Reduction Network (EHRN)
Current harm reduction program at outreach
HIV testing guidance: know, treat, prevent
Pakistan Last updated: July 2015.
The Indigenous HIV/AIDS Epidemic: Are We Invisible?
Hepatitis C Testing, Care and Treatment at Harm Reduction Centres in the European Union: a 28-Country Survey of Service Providers Prof Jeffrey V Lazarus.
WHO minimum public health data set on prison health
No one gets left behind: Addressing the hidden burden of hepatitis C related advanced liver disease in PWID in the community John S Lambert, MD, PhD.
Documenting barriers to access HCV care and treatment: a peer-led research João Santa Maria, Magda Ferreira, Renato Pinto, Joana Sanches, Álvaro Ávila,
Reitox National Focal Point National Bureau for Drug Prevention
Experiences of the Russian Red Cross in Providing Medical/Psychological Assistance to HIV+ women and Children born to HIV+ mothers Irkutsk City (East Siberia)
Core Competency 4: HCV Treatment
Testing and linking different key population groups in Ukraine
People who inject drugs
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Community patient tracking by Lay Community Health Workers (CHWs) is an effective strategy towards the 2nd & 3rd 90 Morapedi Boitumelo M.
The perspective of cities
China 2010 UNGASS Country Progress Report
The HIV Epidemic among People who Inject Drugs
Hepatitis C Testing, Care and Treatment at Harm Reduction Centres in the European Union: a 28-Country Survey of Service Providers Prof Jeffrey V Lazarus.
HIV/HCV testing within low-threshold services for women who use drugs – barriers and recommendations. Alexandra Gurinova, Deutsche AIDS-Hilfe, Germany.
Lesson 3: Treatment as Prevention
Presentation transcript:

HA-REACT Joint Action WP4 Testing and Linkage to care Methods: Trainings in two Focus Countries (Latvia and Hungary) Informational materials for PWUD Training Manual on HIV and HCV rapid testing E-learning course https://harmreduction.eu/

- High prevalence of HIV and HCV cases among PWUD NPS usage Background: - High prevalence of HIV and HCV cases among PWUD NPS usage Limited access to the medical system Low knowledge about own infectious status The project offers: Access to the testing and counselling services close to the scene Anonymous and free of charge Trustful environment Access to additional services on site Although, numbers of new HIV infections in people who inject drugs have stabilised in most western European countries, it remains a big problem in eastern Europe. Number of new HCV cases in PWID grows rapidly, which is also directly connected to the switch in drugs used and injecting practises connected to the NPS. Active drug users are still facing criminalisation and discrimination and therefore very limited access to the medical system. The HA-REACT project offered pwud in Hungary and Latvia access to rapid HIV and HCV testing in low threshold settings. Great part of the testing was on pre and post test counselling, which was designed in a form of “risk awareness”. We also put a big effort to improve linkage to care for those tested positive.

Low threshold settings involved: Latvia 8 cities, 16 NGOs: Hungary 5 cities, 13 NGOs:

Rapid tests used in the project: Latvia (Fingers/ck Whole Blood specimen): CHiL HСV СHiL HIV Hungary (oral tests): HCV OraQuick HIV OraQuick Rapid tests performed by: Latvia: nurses (medical education required) Hungary: social workers and peers (training on rapid testing required)

Latvia: Hungary:

Governmental restrictions towards harm reduction services Hungary. 01 Governmental restrictions towards harm reduction services Low access to PWUD 02 Even though, a shift in drug use from heroin to NPS and amphetamine increased the amount of needles needed as well as the number of individuals seeking help at low threshold settings, the key needle exchange programs in Budapest have been closed in recent years due to political pressure. now there are 3 smaller programs remained with low distribution. Social workers and even peers understand harm reduction as abstinence at the first place, which leads to additional barriers for active PWUD to enter the services. DAA is available and should be accessible for everybody in Hungary, though NGOs participated in the project reported that PWUD are excluded and discriminated by medical stuff. 03 Growing number of new HIV/HCV infections

Latvia In year 2018. new upgrades were implemented in HIV/AIDS policy: the threshold for HIV patients’ treatment was cancelled, a special form for sending a HIV positive patient directly from HPP to infectologist was established. In the nearest future, we should think about possible cost relief for patients. Ministry of Health is currently working on new HIV patient register. Also the ministry believes that Centre for Disease Prevention and Control of Latvia should purchase social mentoring services from HIV prevention points.

Conclusions: Rapid testing must be offered in low threshold settings. Harm reduction programs are an important way to increase HIV/HCV prevention among PWUD. Offer maximum at one place: Consultation-Testing-Treatment Workers must update clients on new HCV treatment options Additional funding to improve linkage to care needed

Thank you! www.hareact.eu/en #HAREACT